View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Capivasertib 400 / Fulvestrant 500 / Goserelin 3.6, Breast Cancer, Cycle 2+
Protocol-ID: 2610 V1.0 (Mini), CAPI400/FLVS500/GOSE3.6, Breast Ca, C2+Indication(s)
- Breast Cancer (HR+, PIK3CA/AKT1/PTEN mutations); ICD-10 C50.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 17.05.2024